The analysis of the expression of these genes in NSCLC cells after the treatment with SFRE indicated the downregulation of TK1 and TYMS (Figure 7B) which may explain, at least partially, the observed synergism between SFRE and cisplatin in the inhibition of cell proliferation. This evidence concerns the gene TYMS and non-small cell lung carcinoma.